Phibro Animal Health Corporation (PAHC) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.045x

Based on the latest financial reports, Phibro Animal Health Corporation (PAHC) has a cash flow conversion efficiency ratio of 0.045x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($16.21 Million) by net assets ($361.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Phibro Animal Health Corporation (PAHC) market capitalisation for the company's overall valuation and market capitalisation.

Phibro Animal Health Corporation - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Phibro Animal Health Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Phibro Animal Health Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Phibro Animal Health Corporation ranked by their cash flow conversion efficiency. Explore Phibro Animal Health Corporation (PAHC) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
GuangDong Rifeng Electric Cable Co Ltd
SHE:002953
0.021x
Omnijoi Media Corp
SHE:300528
0.124x
COMSTOCK HLDG-A
F:CHO
N/A
Eve Holding Inc
NYSE:EVEX
-0.293x
Tipco Asphalt Public Company Limited
BK:TASCO-R
0.046x
Balaji Amines Limited
NSE:BALAMINES
0.011x
Latham Group Inc
NASDAQ:SWIM
0.130x
Ulker Biskuvi Sanayi AS
IS:ULKER
0.050x

Annual Cash Flow Conversion Efficiency for Phibro Animal Health Corporation (2000–2025)

The table below shows the annual cash flow conversion efficiency of Phibro Animal Health Corporation from 2000 to 2025. View PAHC share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 $285.68 Million $80.12 Million 0.280x -17.83%
2024-06-30 $256.64 Million $87.59 Million 0.341x +624.44%
2023-06-30 $282.51 Million $13.31 Million 0.047x -60.93%
2022-06-30 $262.44 Million $31.65 Million 0.121x -40.45%
2021-06-30 $238.53 Million $48.31 Million 0.203x -35.78%
2020-06-30 $188.20 Million $59.35 Million 0.315x +44.41%
2019-06-30 $216.01 Million $47.17 Million 0.218x -42.31%
2018-06-30 $184.95 Million $70.01 Million 0.379x -41.85%
2017-06-30 $151.16 Million $98.40 Million 0.651x +58.26%
2016-06-30 $90.48 Million $37.22 Million 0.411x -82.26%
2015-06-30 $29.63 Million $68.70 Million 2.319x +5033.82%
2014-06-30 $15.15 Million $-712.00K -0.047x -680.74%
2013-06-30 $-68.94 Million $415.00K -0.006x +98.34%
2012-06-30 $-88.23 Million $31.99 Million -0.363x +51.24%
2009-06-30 $-53.88 Million $40.06 Million -0.744x -1483.27%
2007-06-30 $-88.00 Million $-4.73 Million 0.054x +655.42%
2006-06-30 $-83.70 Million $810.00K -0.010x -107.05%
2005-06-30 $-44.90 Million $-6.16 Million 0.137x +406.05%
2004-06-30 $-63.80 Million $2.86 Million -0.045x +89.06%
2003-06-30 $-84.60 Million $34.66 Million -0.410x -627.86%
2002-06-30 $-61.20 Million $-4.75 Million 0.078x -97.99%
2001-06-30 $3.40 Million $13.14 Million 3.865x +1648.81%
2000-06-30 $31.70 Million $-7.91 Million -0.250x --

About Phibro Animal Health Corporation

NASDAQ:PAHC USA Drug Manufacturers - Specialty & Generic
Market Cap
$738.04 Million
Market Cap Rank
#10289 Global
#2762 in USA
Share Price
$35.03
Change (1 day)
-2.53%
52-Week Range
$28.52 - $59.58
All Time High
$59.58
About

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including po… Read more